ABSTRACT
OBJECTIVES: To evaluate outcomes of patients achieving a post-treatment pathological stage of Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
, Neoplasm Recurrence, Local/pathology
, Urinary Bladder Neoplasms/drug therapy
, Urinary Bladder Neoplasms/pathology
, Adult
, Aged
, Aged, 80 and over
, Antineoplastic Combined Chemotherapy Protocols/administration & dosage
, Chemotherapy, Adjuvant
, Cisplatin/administration & dosage
, Cystectomy
, Deoxycytidine/administration & dosage
, Deoxycytidine/analogs & derivatives
, Doxorubicin/administration & dosage
, Female
, Humans
, Internationality
, Kaplan-Meier Estimate
, Male
, Methotrexate/administration & dosage
, Middle Aged
, Muscle, Smooth/pathology
, Neoadjuvant Therapy
, Neoplasm Invasiveness
, Neoplasm Metastasis
, Neoplasm Staging
, Proportional Hazards Models
, Risk Factors
, Time Factors
, Urinary Bladder/pathology
, Urinary Bladder Neoplasms/surgery
, Vinblastine/administration & dosage
, Gemcitabine